General Cannabis Inc. (CANA) has been moving steadily forward on the new frontier of medicinal cannabis internet services. Beyond their upwards revenue trajectory, acquisitions and personnel growth, the company has joined the OTCQX, the OTC market’s highest tier. This is a major stride for the technology based internet marketing services company, as the higher tier and more rigorous requirements it entails will help assure investors of the authenticity of this new terrain.
In a Press Release from the OTC Markets Group, the company’s President and Chief Executive Officer, R.Cromwell Coulson said, “Investors prefer the quality-controlled admission process on OTCQX which identifies the segment of OTC companies focused on valuation and transparency.”
The growing legitimacy of the OTC Markets, especially the OTCQX, parallels the changing attitudes toward medicinal cannabis. While years ago, many worried about pump and dump stocks in the darker corners of the OTC, the continual regulation and standards demanded of companies today have made it a well respected market and home to countless high quality money making opportunities.
The same could be said of the new frontier of medicinal cannabis. Now legal in 16 states with more considering legislation, medicinal cannabis is increasingly recognized for its healthcare applications and as a potential business endeavor.
For its part, General Cannabis has been a leader in the growing industry. The company has observed rising demand for its services, which include the intelligent application of software designed to monetize efficiencies between buyers and sellers. The landscape of medicinal cannabis is changing as it becomes legal in more and more states. On this scale, medicinal marijuana sales deserve to be taken more seriously and General Cannabis is leading the way in making sure that happen.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer